• Cell, Gene Therapy Manufacturing As Large-Scale Biology

    Bio-IT World Contributed Commentary | The last three years we have witnessed an exponential expansion of the cell and gene therapy space, both in the number of cell and gene therapies approved or in development, and the real and projected values of the market. This growth is rapidly changing the way we think about what medicines are.

    Jul 23, 2020

  • PacBio’s Focus on Human Genomics And Read Length Sweet Spot

    Bio-IT World | It seems like a very long time ago, now, that Illumina and Pacific Biosciences dissolved their merger agreement, but in fact their announcement is just about six months old. Since then, PacBio has been busy reestablishing itself as an independent business and looking ahead, their sights set on the human genome sequencing market.

    Jul 21, 2020

  • How Mass Spectrometry is Accelerating Quantitative Proteomics

    Bio-IT World Contributed Commentary | Mass spectrometry has transitioned from being used mostly in routine analytical applications to becoming a powerful biological method for protein quantitation.

    Jul 20, 2020

  • Populations With Unique Enzymes More Susceptible To COVID-19, Other News

    Bio-IT World | Researchers from Cleveland Clinic have found unique genetic susceptibility to COVID-19 across populations in ACE2 and TMPRSS2. Elsewhere, the University of California Health has developed a unified, secure data set for use in COVID-19 research. This, plus more, is included in this week’s COVID-19 news from the biotech and research industries.

    Jul 16, 2020

  • In The Midst Of A Pandemic, Duplex Sequencing Comes Of Age

    Bio-IT World | Duplex Sequencing, a technique for improving the accuracy of next-generation sequencing by more than 10,000-fold, could eliminate a good deal of the guesswork in advancing drugs to market.

    Jul 15, 2020

  • Breaking Silos to Enable Breakthroughs

    Bio-IT World | TRENDS FROM THE TRENCHES | For most big pharma and other global enterprises, decades of growth have resulted in siloed operations, even as they seek breakthrough medicines. It is time for such a breakthrough; as an industry, we’re overdue.

    Jul 14, 2020